IL149528A0 - Condensed azepines as vasopressin agonists - Google Patents

Condensed azepines as vasopressin agonists

Info

Publication number
IL149528A0
IL149528A0 IL14952801A IL14952801A IL149528A0 IL 149528 A0 IL149528 A0 IL 149528A0 IL 14952801 A IL14952801 A IL 14952801A IL 14952801 A IL14952801 A IL 14952801A IL 149528 A0 IL149528 A0 IL 149528A0
Authority
IL
Israel
Prior art keywords
vasopressin agonists
azepines
condensed
condensed azepines
vasopressin
Prior art date
Application number
IL14952801A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL149528A0 publication Critical patent/IL149528A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL14952801A 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists IL149528A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000079.4A GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents
PCT/GB2001/000023 WO2001049682A1 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists

Publications (1)

Publication Number Publication Date
IL149528A0 true IL149528A0 (en) 2002-11-10

Family

ID=9883168

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14952801A IL149528A0 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists

Country Status (34)

Country Link
US (3) US7074781B2 (et)
EP (1) EP1248784B1 (et)
JP (2) JP3869723B2 (et)
KR (1) KR100605466B1 (et)
CN (1) CN1183129C (et)
AR (1) AR035327A1 (et)
AT (1) ATE366730T1 (et)
AU (1) AU777538B2 (et)
BR (1) BR0107414B1 (et)
CA (1) CA2396277C (et)
CY (1) CY1108034T1 (et)
CZ (1) CZ303444B6 (et)
DE (1) DE60129298T2 (et)
DK (1) DK1248784T3 (et)
EE (1) EE200200367A (et)
ES (1) ES2288923T3 (et)
GB (1) GB0000079D0 (et)
HK (1) HK1046910B (et)
HR (1) HRP20020481B1 (et)
HU (1) HU229937B1 (et)
IL (1) IL149528A0 (et)
MX (1) MXPA02006546A (et)
MY (1) MY140467A (et)
NO (1) NO322571B1 (et)
NZ (1) NZ518803A (et)
PL (1) PL211341B1 (et)
PT (1) PT1248784E (et)
RU (1) RU2259367C2 (et)
SI (1) SI1248784T1 (et)
SK (1) SK287005B6 (et)
UA (1) UA73152C2 (et)
UY (1) UY26521A1 (et)
WO (1) WO2001049682A1 (et)
ZA (1) ZA200205180B (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
DE60120940T2 (de) * 2000-03-27 2007-01-25 Applied Research Systems Ars Holding N.V. Pyrrolidin-derivate verwendbar als bax-inhibitoren
ES2262640T3 (es) * 2000-03-27 2006-12-01 Applied Research Systems Ars Holding N.V. Derivados de pirrolidina farmaceuticamente activos como inhibidores de bax.
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
MXPA05011521A (es) * 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
DE60305043T2 (de) * 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
CA2588768A1 (en) * 2004-11-17 2006-05-26 Kissei Pharmaceutical Co., Ltd. Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
EP1867639A1 (en) * 2005-03-25 2007-12-19 Kissei Pharmaceutical Co., Ltd. Urea derivative, medicinal composition containing the same, and medicinal use of these
WO2007052517A1 (ja) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited ヒドロキシ-2-ピロリジンカルボキシアミド化合物の製法
WO2008038600A1 (fr) * 2006-09-25 2008-04-03 Kissei Pharmaceutical Co., Ltd. Dérivé de 1,4-benzodiazépine, composition pharmaceutique qui le comprend et son utilisation dans des buts médicaux
EA017249B8 (ru) * 2007-05-10 2013-01-30 Олбани Молекьюлар Рисерч, Инк. Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
CA2724653A1 (en) * 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960886A (en) 1968-07-03 1976-06-01 Sterling Drug Inc. Substituted N-arylanilines
CA1047490A (en) 1973-04-18 1979-01-30 Friedrich Karrer Ethers
CH599752A5 (et) 1973-04-18 1978-05-31 Ciba Geigy Ag
DE2355454A1 (de) 1973-11-07 1976-10-07 Paul Geisslinger Lochmaschine
CA1265798A (en) 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
KR0167349B1 (ko) 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
US5753677A (en) 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
TW198715B (et) 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
JPH05320135A (ja) * 1992-05-19 1993-12-03 Yamanouchi Pharmaceut Co Ltd テトラヒドロベンズアゼピン誘導体
EP0612319A1 (en) 1992-08-20 1994-08-31 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
TW270927B (et) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
WO1994012476A1 (en) * 1992-11-25 1994-06-09 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
WO1994020473A1 (en) 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5516774A (en) 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5968930A (en) 1993-07-29 1999-10-19 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5760031A (en) 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5843952A (en) 1993-07-29 1998-12-01 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
FI1215U1 (fi) * 1993-12-03 1994-02-21 Valmet Paper Machinery Inc Anlaeggning i samband med styrningen av en vira
WO1995031034A2 (en) * 1994-05-06 1995-11-16 Philips Electronics N.V. Microwave transmission system
US6096735A (en) 1994-06-15 2000-08-01 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic derivatives
JP2926335B2 (ja) * 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
BR9811585A (pt) * 1997-07-30 2000-09-26 American Home Prod Agonistas de vasopressinas tricìclicas
ES2229523T3 (es) * 1997-07-30 2005-04-16 Wyeth Agonistas triciclicos de la vasopresina.
ES2216579T3 (es) 1998-10-09 2004-10-16 Janssen Pharmaceutica N.V. Derivados de 4,5-dihidro-isoxazol y su uso farmaceutico.
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
DE10033337A1 (de) 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB0120051D0 (en) 2001-08-16 2001-10-10 Ferring Bv Oxytocin agonists
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1449844A1 (en) 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP1627876A1 (en) 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
US7341963B2 (en) * 2005-05-17 2008-03-11 Milliken & Company Non-woven material with barrier skin

Also Published As

Publication number Publication date
PL355808A1 (en) 2004-05-17
PT1248784E (pt) 2007-10-02
HRP20020481B1 (en) 2009-03-31
MY140467A (en) 2009-12-31
US7560454B2 (en) 2009-07-14
EP1248784B1 (en) 2007-07-11
UA73152C2 (en) 2005-06-15
RU2002120798A (ru) 2004-01-10
SK9112002A3 (en) 2003-01-09
HK1046910B (zh) 2007-08-31
SI1248784T1 (sl) 2007-12-31
CZ303444B6 (cs) 2012-09-19
AU2384601A (en) 2001-07-16
NO20023137L (no) 2002-06-27
JP2006137767A (ja) 2006-06-01
UY26521A1 (es) 2001-03-16
ATE366730T1 (de) 2007-08-15
SK287005B6 (sk) 2009-09-07
CN1392875A (zh) 2003-01-22
HUP0203917A2 (hu) 2003-03-28
CN1183129C (zh) 2005-01-05
NO20023137D0 (no) 2002-06-27
JP3869723B2 (ja) 2007-01-17
DE60129298T2 (de) 2008-01-03
HU229937B1 (hu) 2015-01-28
HK1046910A1 (en) 2003-01-30
NZ518803A (en) 2003-03-28
CY1108034T1 (el) 2013-09-04
BR0107414A (pt) 2002-10-08
ES2288923T3 (es) 2008-02-01
EE200200367A (et) 2003-12-15
KR20020063191A (ko) 2002-08-01
US20080261951A1 (en) 2008-10-23
JP2003519228A (ja) 2003-06-17
HRP20020481A2 (en) 2004-08-31
US20060154916A1 (en) 2006-07-13
WO2001049682A1 (en) 2001-07-12
HUP0203917A3 (en) 2004-07-28
US20030087892A1 (en) 2003-05-08
CA2396277C (en) 2012-03-20
PL211341B1 (pl) 2012-05-31
BR0107414B1 (pt) 2014-09-16
AU777538B2 (en) 2004-10-21
JP3813629B2 (ja) 2006-08-23
GB0000079D0 (en) 2000-02-23
NO322571B1 (no) 2006-10-30
RU2259367C2 (ru) 2005-08-27
DE60129298D1 (de) 2007-08-23
CA2396277A1 (en) 2001-07-12
MXPA02006546A (es) 2002-12-09
ZA200205180B (en) 2004-02-05
EP1248784A1 (en) 2002-10-16
AR035327A1 (es) 2004-05-12
KR100605466B1 (ko) 2006-07-28
DK1248784T3 (da) 2007-10-29
CZ20022305A3 (cs) 2002-10-16
US7074781B2 (en) 2006-07-11

Similar Documents

Publication Publication Date Title
HK1046910A1 (en) Condensed azepines as vasopressin agonists
HRP20030383A2 (en) Lactam compound
GB2358341B (en) Clothing
HK1041178A1 (zh) 有杯罩衣物
IL155275A0 (en) Lactam compound
GB0020273D0 (en) Chemical composition
GB0003069D0 (en) Improved assay
GB0129519D0 (en) Sock
GB0009854D0 (en) Clothing
GB0121539D0 (en) Lint remover container
GB2377170B (en) Clothes line
GB0015521D0 (en) Clothing
IL136686A0 (en) Garments
GB0020254D0 (en) Big shirt
CA89640S (en) Dual fragrance bottle
GB0018545D0 (en) Clothes line
CA90477S (en) Fork
CA89803S (en) Fork
GB0001312D0 (en) Clothing
GB0027962D0 (en) Easyfit trouser
PL340024A1 (en) Trouser
GB0027109D0 (en) Clothes line
GB0022657D0 (en) Clothes Line
GB0004115D0 (en) Dual container
AU5203201A (en) Fluorescent compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed